We thus demonstrate that the anti-OPN antibody treatment results in the rescue of BBB function in ischemic stroke, leading to a decrease in cerebral edema and to a reduced risk for haemorrhagic transformation. The gene discussed is SPP1; the disease is ischemic stroke.